Average Co-Inventor Count = 5.97
ph-index = 16
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Celgene Avilomics Research, Inc. (31 from 44 patents)
2. Celgene Car LLC (28 from 44 patents)
3. Biogen Idec Ma Inc. (9 from 216 patents)
4. Sanofi (7 from 1,456 patents)
5. Avila Therapeutics, Inc. (5 from 5 patents)
6. Biogen, Incorporated (3 from 130 patents)
7. Mersana Therapeutics, Inc. (3 from 36 patents)
8. Other (1 from 832,912 patents)
9. Curis, Inc. (1 from 141 patents)
10. Biogen Idec, Inc. (1 from 46 patents)
11. Biogen Ma Inc. (251 patents)
12. Epizyme, Inc. (158 patents)
81 patents:
1. 11584757 - MK2 inhibitors and uses thereof
2. 11542492 - Ligand-directed covalent modification of protein
3. 11351168 - 2,4-disubstituted pyrimidines useful as kinase inhibitors
4. 11096942 - Heterocyclic compounds and uses thereof
5. 11098061 - MK2 inhibitors and uses thereof
6. 10828300 - Substituted 2,4-diaminopyrimidines as kinase inhibitors
7. 10774052 - Heteroaryl compounds and uses thereof
8. 10662195 - Protein kinase conjugates and inhibitors
9. 10618902 - Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases
10. 10596172 - 2,4-disubstituted pyrimidines useful as kinase inhibitors
11. 10577380 - MK2 inhibitors and uses thereof
12. 10434101 - Heterocyclic compounds and uses thereof
13. 10253040 - MK2 inhibitors and uses thereof
14. 10189794 - Heteroaryl compounds and uses thereof
15. 10138256 - MK2 inhibitors and uses thereof